The expression of BMP, integrin, ZEB2 in ovarian high-grade serous carcinoma in relation with lymph node metastasis

被引:1
|
作者
Zirh, Elham Bahador [1 ,2 ]
Kapakli, Elif Tasar [3 ]
Dolgun, Anil [4 ]
Usubutun, Alp [3 ]
Zeybek, Naciye Dilara [2 ]
机构
[1] TOBB Econ & Technol Univ, Fac Med, Dept Histol & Embryol, Ankara, Turkey
[2] Hacettepe Univ, Fac Med, Dept Histol & Embryol, TR-06100 Ankara, Turkey
[3] Hacettepe Univ, Fac Med, Dept Pathol, Ankara, Turkey
[4] RMIT Univ, Dept Math Sci, Melbourne, Vic, Australia
关键词
High-grade ovarian cancer; lymph node metastasis; BMP2; BMP7; integrin alpha 5; integrin beta 1; ZEB2; EPITHELIAL-MESENCHYMAL TRANSITION; CANCER CELLS; GENE-EXPRESSION; BREAST-CANCER; TGF-BETA; BONE; INHIBITION; PROTEINS; SURVIVAL;
D O I
10.1080/08977194.2022.2099849
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Ovarian cancer (OC) is clinically important because it is diagnosed late and has metastasis when it is diagnosed. Mortality risk increases 2.75 times in the presence of lymph node (LN) metastasis. During metastasis, many molecules including BMPs originated from stroma, and tumor cells participate through transcription factors and integrins for cytoskeleton regulation during cell migration. We hypothesized an inverse correlation between BMP2 and BMP7 along with changes in ZEB2, and integrin alpha 5 beta 1 in high-grade OCs in relation to LN metastasis. The BMP2 immunoreactivity was strong along with strong ZEB2 and weak integrins' immunoreactivity in samples with LN metastasis. Strong immunoreactivity of BMP7 was accompanied by strong immunoreactivity of integrins in the samples without LN metastasis. Study results showed BMP2's strong positive immunoreactivity and weak BMP7 immunoreactivity in tumor cells with a significantly weak inverse correlation. This inverse correlation should be considered as both BMPs have different effects in the window of cancer progression and invasion.
引用
收藏
页码:153 / 162
页数:10
相关论文
共 50 条
  • [41] Inhibition of CDK2 reduces EZH2 phosphorylation and reactivates ERα expression in high-grade serous ovarian carcinoma
    Han, Ye
    Wei, Yongkun
    Yao, Jun
    Chu, Yu-Yi
    Li, Chia-Wei
    Hsu, Jennifer L.
    Nie, Lei
    Hung, Mien-Chie
    AMERICAN JOURNAL OF CANCER RESEARCH, 2020, 10 (04): : 1194 - +
  • [42] Shortened Telomeres in Serous Tubal Intraepithelial Carcinoma: An Early Event in Ovarian High-grade Serous Carcinogenesis
    Kuhn, Elisabetta
    Meeker, Alan
    Wang, Tian-Li
    Sehdev, Ann Smith
    Kurman, Robert J.
    Shih, Ie-Ming
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2010, 34 (06) : 829 - 836
  • [43] Recurrent Somatic Copy Number Alterations and Their Association with Oncogene Expression Levels in High-Grade Ovarian Serous Carcinoma
    Esplen, Hillary P.
    Yang, Richard K.
    Kalia, Awdhesh
    Tang, Zhenya
    Tang, Guilin
    Medeiros, L. Jeffrey
    Toruner, Gokce A.
    LIFE-BASEL, 2023, 13 (11):
  • [44] Low levels of IGFBP7 expression in high-grade serous ovarian carcinoma is associated with patient outcome
    Karen Gambaro
    Michael CJ Quinn
    Katia Y Cáceres-Gorriti
    Rebecca S Shapiro
    Diane Provencher
    Kurosh Rahimi
    Anne-Marie Mes-Masson
    Patricia N Tonin
    BMC Cancer, 15
  • [45] Co-expression of VEGF and CA9 in ovarian high-grade serous carcinoma and relationship to survival
    Williams, Emma
    Martin, Stewart
    Moss, Robert
    Durrant, Lindy
    Deen, Suha
    VIRCHOWS ARCHIV, 2012, 461 (01) : 33 - 39
  • [46] Calreticulin expression is reduced in high-grade ovarian serous carcinoma effusions compared with primary tumors and solid metastases
    Vaksman, Olga
    Davidson, Ben
    Trope, Claes
    Reich, Reuven
    HUMAN PATHOLOGY, 2013, 44 (12) : 2677 - 2683
  • [47] Prognostic impact of HER3 based on protein and mRNA expression in high-grade serous ovarian carcinoma
    Unger, Ulrike
    Denkert, Carsten
    Braicu, Ioana
    Sehouli, Jalid
    Dietel, Manfred
    Loibl, Sibylle
    Darb-Esfahani, Silvia
    VIRCHOWS ARCHIV, 2017, 470 (02) : 143 - 151
  • [48] The role of distinct BRD4 isoforms and their contribution to high-grade serous ovarian carcinoma pathogenesis
    Drumond-Bock, Ana Luiza
    Bieniasz, Magdalena
    MOLECULAR CANCER, 2021, 20 (01)
  • [49] Low levels of IGFBP7 expression in high-grade serous ovarian carcinoma is associated with patient outcome
    Gambaro, Karen
    Quinn, Michael C. J.
    Caceres-Gorriti, Katia Y.
    Shapiro, Rebecca S.
    Provencher, Diane
    Rahimi, Kurosh
    Mes-Masson, Anne-Marie
    Tonin, Patricia N.
    BMC CANCER, 2015, 15
  • [50] The Claudin-Low Subtype of High-Grade Serous Ovarian Carcinoma Exhibits Stem Cell Features
    Romani, Chiara
    Capoferri, Davide
    Grillo, Elisabetta
    Silvestri, Marco
    Corsini, Michela
    Zanotti, Laura
    Todeschini, Paola
    Ravaggi, Antonella
    Bignotti, Eliana
    Odicino, Franco
    Sartori, Enrico
    Calza, Stefano
    Mitola, Stefania
    CANCERS, 2021, 13 (04) : 1 - 18